Prashant R Nambiar Selected Research

Prashant R Nambiar Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 07/2002
5	Body Weight (Weight, Body) 07/2015 - 02/2003
5	Carcinoma (Carcinomatosis) 04/2015 - 01/2006
5	Carcinogenesis 12/2007 - 01/2003
4	Colorectal Neoplasms (Colorectal Cancer) 11/2010 - 01/2003
4	Colonic Neoplasms (Colon Cancer) 05/2008 - 09/2004
3	Adenocarcinoma 04/2015 - 01/2006
3	Inflammation (Inflammations) 01/2007 - 01/2006
2	Adenoma (Adenomas) 04/2015 - 08/2006
2	Colitis 01/2007 - 11/2006
1	Testicular Neoplasms (Testicular Cancer) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hyperplasia 04/2015
1	Hypertrophy 04/2015
1	Urinary Calculi (Urinary Calculus) 04/2015
1	Liver Cell Adenoma (Hepatocellular Adenoma) 04/2015
1	Transitional Cell Carcinoma 04/2015
1	Graves Disease (Basedow Disease) 08/2014
1	Hyperthyroidism 08/2014
1	Thyrotoxicosis 08/2014
1	Hemangiosarcoma (Angiosarcoma) 01/2013
1	Pheochromocytoma 01/2013
1	Thyroid Neoplasms (Thyroid Cancer) 09/2012
1	Neoplasm Metastasis (Metastasis) 09/2012
1	Hypoxia (Hypoxemia) 09/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012
1	Intestinal Neoplasms (Intestinal Cancer) 05/2008
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2007
1	Gastritis 01/2007
1	Intestinal Polyposis (Polyposis, Intestinal) 01/2006
1	Communicable Diseases (Infectious Diseases) 11/2005
1	Enterotoxemia 06/2005
1	Helicobacter Infections 06/2005
1	Chronic Hepatitis (Chronic Active Hepatitis) 06/2005
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2004
1	Aberrant Crypt Foci 09/2004

Drug/Important Bio-Agent (IBA)

8	AzoxymethaneIBA 10/2006 - 07/2002
5	Proteins (Proteins, Gene)FDA Link 09/2012 - 07/2002
4	CarcinogensIBA 05/2008 - 01/2003
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2008 - 02/2003
3	CytokinesIBA 01/2021 - 01/2006
3	EnzymesIBA 04/2015 - 02/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006 - 02/2003
3	Complementary DNA (cDNA)IBA 09/2004 - 07/2002
3	Messenger RNA (mRNA)IBA 05/2003 - 07/2002
2	Serine Proteases (Serine Protease)IBA 09/2012 - 05/2003
2	Biomarkers (Surrogate Marker)IBA 11/2010 - 09/2004
2	Prostaglandins EIBA 05/2008 - 02/2003
2	InterleukinsIBA 12/2007 - 08/2006
2	Interleukin-10 (Interleukin 10)IBA 12/2007 - 11/2006
2	beta CateninIBA 09/2004 - 01/2003
2	SolutionsIBA 05/2003 - 02/2003
2	Saline SolutionIBA 05/2003 - 02/2003
2	DNA (Deoxyribonucleic Acid)IBA 02/2003 - 07/2002
1	AntigensIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	antineoplaston A10 (A 10)IBA 07/2015
1	UK 453,061IBA 04/2015
1	Reverse Transcriptase InhibitorsIBA 04/2015
1	Methimazole (Thiamazole)FDA LinkGeneric 08/2014
1	Propylthiouracil FDA Link 08/2014
1	bazedoxifeneIBA 01/2013
1	Sunitinib (Sutent)FDA Link 01/2013
1	AntibodiesIBA 09/2012
1	Carbonic Anhydrase IXIBA 09/2012
1	ProstaglandinsIBA 05/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2008
1	Dextrans (Dextran)FDA Link 01/2007
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2007
1	Drinking WaterIBA 01/2007
1	NF-kappa B (NF-kB)IBA 11/2006
1	Tumor Suppressor Protein p53IBA 10/2006
1	nutlin 3IBA 10/2006
1	Polychlorinated Biphenyls (PCBs)IBA 11/2005
1	Metronidazole (Metric)FDA LinkGeneric 06/2005
1	CDTA (DCTA)IBA 06/2005
1	cytolethal distending toxinIBA 06/2005
1	BismuthIBA 06/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2005
1	Amoxicillin (Wymox)FDA LinkGeneric 06/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2005
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2004
1	Cyclin D1IBA 09/2004
1	RNA (Ribonucleic Acid)IBA 09/2004
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2003
1	Thrombospondin 1IBA 05/2003
1	Fibrinolysin FDA Link 05/2003
1	ImmunosorbentsIBA 05/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2003
1	Plasminogen Activator Inhibitor 1IBA 05/2003
1	Growth InhibitorsIBA 05/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2003
1	PlasminogenIBA 05/2003
1	Peptides (Polypeptides)IBA 05/2003
1	LigandsIBA 05/2003

Therapy/Procedure

1	Immunotherapy 01/2021
1	Chemoprevention 05/2008
1	Aftercare (After-Treatment) 12/2007
1	Injections 09/2004